The 10-day RSI Oscillator for CKPT moved out of overbought territory on December 03, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CKPT as a result. In of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CKPT turned negative on December 09, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CKPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where CKPT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
CKPT moved above its 50-day moving average on December 20, 2024 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CKPT advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .
CKPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 146 cases where CKPT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CKPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). CKPT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). CKPT's P/S Ratio (2500.000) is slightly higher than the industry average of (256.215).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CKPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
a biopharmaceutical company
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSTLX | 30.99 | 0.42 | +1.37% |
Federated Hermes MDT Large Cap Value R6 | |||
CCQYX | 15.01 | 0.20 | +1.35% |
Columbia Disciplined Core Inst3 | |||
PETGX | 14.50 | 0.11 | +0.76% |
Gabelli Pet Parents'™ A | |||
MCCRX | 16.30 | 0.10 | +0.62% |
MassMutual Small Cap Opps R3 | |||
JTKIX | 10.70 | -3.36 | -23.90% |
JHancock Global Thematic Opps I |
A.I.dvisor indicates that over the last year, CKPT has been loosely correlated with CYCC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CKPT jumps, then CYCC could also see price increases.
Ticker / NAME | Correlation To CKPT | 1D Price Change % | ||
---|---|---|---|---|
CKPT | 100% | +11.28% | ||
CYCC - CKPT | 52% Loosely correlated | -4.11% | ||
GPCR - CKPT | 43% Loosely correlated | -6.91% | ||
CYTK - CKPT | 42% Loosely correlated | +4.56% | ||
CARA - CKPT | 40% Loosely correlated | +3.35% | ||
AXON - CKPT | 37% Loosely correlated | +2.60% | ||
More |